NMPA officially joins Medical Device Regulators Forum (IMDRF) National Competent Authorities Report (NCAR) Exchange Program

On September 19, 2019 the IMDRF approved the Chinese National Medical Products Administration (NMPA) to join the IMDRF National Competent Authorities Report (NCAR) Exchange Program.

The IMDRF NCAR Exchange Program was established to set up channels for sharing information on medical device safety among drug regulatory agencies of different countries, enabling member countries to exchange information in a timely manner on medical device adverse events that could trigger serious public health issues or indicate potential risk trends.

NMPA participation in the mechanism provides China with access to safety information on international medical device adverse events and facilitates evaluation and control of the risks associated with imported products, so that NMPA is better positioned to protect and promote public health.

Read more online
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /